Education
About Us
Working with TipRanks
Follow Us
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
APVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.30 - $613.24
Previous CloseN/A
Volume25.11K
Average Volume (3M)279.42K
Market Cap
$3.27M
Enterprise Value$424.71M
Total Cash (Recent Filing)$2.14M
Total Debt (Recent Filing)$4.42M
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Aug 07, 2025EPS Estimate
-83.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-87.80
Shares Outstanding700,000
10 Day Avg. Volume132,163
30 Day Avg. Volume279,415
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)24.36
Price to Sales (P/S)0.00
P/FCF Ratio-20.80
Enterprise Value/Market Cap129.92
Enterprise Value/Revenue235.43
Enterprise Value/Gross Profit4.01K
Enterprise Value/Ebitda-4.34
Forecast
1Y Price Target
$21.00Price Target Upside351.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Aptevo Therapeutics News
PremiumCompany Announcements
Aptevo Therapeutics Approves 1-for-20 Reverse Stock Split
PremiumCompany Announcements
Aptevo Therapeutics Announces Reverse Stock SplitOptions Prices
Currently, No data available
---
Ownership Overview
0.60% Insiders
0.02% Mutual Funds
0.03% Other Institutional Investors
99.34% Public Companies and Individual Investors
APVO FAQ
What was Aptevo Therapeutics Inc’s price range in the past 12 months?
Aptevo Therapeutics Inc lowest stock price was $4.30 and its highest was $613.24 in the past 12 months.
What is Aptevo Therapeutics Inc’s market cap?
Aptevo Therapeutics Inc’s market cap is $3.27M.
When is Aptevo Therapeutics Inc’s upcoming earnings report date?
Aptevo Therapeutics Inc’s upcoming earnings report date is Aug 07, 2025 which is in 56 days.
How were Aptevo Therapeutics Inc’s earnings last quarter?
Aptevo Therapeutics Inc released its earnings results on May 15, 2025. The company reported -$87.8 earnings per share for the quarter, missing the consensus estimate of -$84.2 by -$3.6.
Is Aptevo Therapeutics Inc overvalued?
According to Wall Street analysts Aptevo Therapeutics Inc’s price is currently Undervalued.
Does Aptevo Therapeutics Inc pay dividends?
Aptevo Therapeutics Inc does not currently pay dividends.
What is Aptevo Therapeutics Inc’s EPS estimate?
Aptevo Therapeutics Inc’s EPS estimate is -83.2.
How many shares outstanding does Aptevo Therapeutics Inc have?
Aptevo Therapeutics Inc has 700,000 shares outstanding.
What happened to Aptevo Therapeutics Inc’s price movement after its last earnings report?
Aptevo Therapeutics Inc reported an EPS of -$87.8 in its last earnings report, missing expectations of -$84.2. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aptevo Therapeutics Inc?
Currently, no hedge funds are holding shares in APVO
Company Description
Aptevo Therapeutics Inc
Aptevo Therapeutics (APVO) is a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics aimed at providing innovative treatments for cancer and other life-threatening diseases. The company operates primarily in the biotechnology and pharmaceutical sectors, leveraging its proprietary ADAPTIR and ADAPTIR-FLEX platforms to create bispecific antibody therapeutics. Aptevo's core products include APVO436, a bispecific antibody candidate targeting acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), among other developmental candidates.